Check Out What's Happening at the Center for Tobacco Products
- CTP’s First Cooperative Agreement to Develop a Cigarette Tobacco Reference Products Program
- CTP at This Year's American Association for Cancer Research Meeting
- The Ombudsman's Office Releases 2013 Annual Report
CTP’s First Cooperative Agreement to Develop a Cigarette Tobacco Reference Products Program
FDA is excited to announce the first cooperative agreement award for the Cigarette Tobacco Reference Products Program. FDA’s Center for Tobacco Products will be collaborating with the University of Kentucky to develop a high quality cigarette tobacco reference product representing American blended cigarettes to be used for investigational, non-clinical purposes by tobacco manufacturers, contract and government laboratories, and academic institutions.
The development of a cigarette tobacco reference product will enable an accurate and thorough scientific characterization of cigarette tobacco products. Tobacco reference products could be used by tobacco product manufacturers, academic researchers, and contract and government laboratories for investigational and quality control purposes including proficiency testing, instrument calibration, employee training, and method validation.
This program will make the analyses of cigarette constituents more accurate and reliable, helping to ensure that accurate scientific data are collected to help fill current gaps regarding the chemical and physical properties of tobacco products, and more generally, improve information regarding the harms associated with tobacco use.
Find out more about the Cigarette Tobacco Reference Products Program here, or contact Candice Jongsma, Chemistry Team Leader, at email@example.com.
CTP at This Year's American Association for Cancer Research Meeting
CTP will be participating in the American Association for Cancer Research (AACR) Annual Meeting 2014 being held in San Diego on April 5-9. Join us for the following activities:
- Advancing Tobacco Regulatory Science: Meet the Experts in FDA's Center for Tobacco Products - Saturday, April 5, 1-3 p.m. PDT
CTP will provide an overview of tobacco regulatory science, current FDA tobacco research and regulatory sciences initiatives, including those in partnership with the Centers for Disease Control and Prevention and the National Institutes of Health, such as the Population Assessment of Tobacco and Health (PATH) Study.
- Public Listening Session - Saturday, April 5, 6:30-8:30 p.m. PDT
CTP’s Office of Science is holding a public listening session in conjunction with the AACR meeting. CTP is particularly interested in hearing from the public on Center priorities, including preventing youth tobacco initiation; encouraging adults who use tobacco to quit; reducing product harms and addictiveness; and developing a science base, and continuing meaningful product regulation. Several individuals have already registered ahead of time to present, but if time allows, we will hear from additional volunteers.
- Honoring the 50th Anniversary of the Surgeon General' Report: The Health Consequences of Smoking--50 Years of Progress - Monday, April 7, 10:30 a.m. -12:30 p.m. PDT
CTP Director Mitch Zeller will participate as a panelist during this session, which will address smoking patterns and the evolution of tobacco control over the last 50 years. Among other topics, speakers will also discuss challenges to future tobacco control efforts and federal research and regulatory efforts aimed at further understanding and reducing the negative health consequences of smoking and other forms of tobacco use.
The Ombudsman's Office Releases 2013 Annual Report
CTP established its Ombudsman’s Office in 2010 and appointed Les Weinstein to serve as the first Ombudsman. The Ombudsman’s Office responds to a wide range of complaints from various stakeholders and the public, and facilitates the resolution of disputes between CTP and the tobacco industry. While providing this service, the CTP Ombudsman strives to maintain impartiality and neutrality. This Annual Report summarizes the role of the Ombudsman’s Office and the complaints, disputes, and inquiries/comments it received for calendar year 2013. Les Weinstein retired in October 2013, and the Acting Ombudsman is Ella Yeargin.
Visit the CTP Ombudsman webpage to read the report and find more information.